The Effects of Anodal tsDCS on Chronic Neuropathic Pain After SCI
Unknown statusNot applicableNCT02863315
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the analgesic effect of transcutaneous spinal direct current stimulation (tsDCS) applied on spinal cord in patients with spinal cord injury who have chronic neuropathic pain.
Study details
- Official title
- The Effects of Anodal Transcutaneous Spinal Direct Current Stimulation on Chronic Neuropathic Pain After Spinal Cord Injury: Pilot Study
- Conditions
- Interventions
- Device: tsDCS
- Sponsor
- Seoul National University Hospital
- Start date
- 2016-08
- Primary completion
- 2017-09
- Sex
- All
- Age range
- from 20 Years to 90 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. cervical or upper thoracic complete motor spinal cord injury, at least 6 months after SCI, 20\<=age\<90 2. neuropathic pain (LANSS score \>= 12), stable chronic pain for at least the three preceding months but not over 5 years 3. score higher than or equal to 4 cm (0 cm = 'no pain' and 10 cm = 'worst possible pain') on the visual ana- logue scale (VAS) for pain perception at the baseline/start of the treatment 4. refractoriness to drugs for pain relief - such as tricyclic antidepressants, antiepileptic drugs, and/or narcot- ics (pain resistant to at least two of these drugs supplied in ade- quate dosages for 6 months) 5. informed consent Exclusion Criteria: 1. patients with any clinically significant or unstable medical or progressive neurologic disorder 2. contraindication for electrial stimulation such as pacemaker implant 3. Women of childbearing age or pregnancy 4. significant cognitive deficit 5. Syringomyelia 6. neuropsychiatric comorbidity 7. depressive disorder (as indicated by a score of 10 greater on the Beck Depression Inventory) 8. history of substance abuse 9. skin defect under the electrodes 10. progressive neurological disease or other secondary conditions that could impact neuropathic pain
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02863315